ZIMMER BIOMET HOLDINGS, INC.
Company Stats
- Market Cap
- $16.9B
- as of Sep 30, 2026
- Shares Outstanding
- 190.7M
- Free Float
- 95.9%
Income Statement
- Revenue
- $8.2B
- Operating Income
- $1.1B
- Net Income
- $705.1M
- EBITDA
- $2.2B
- Revenue Growth, 3Y
- 5.9%
- FCF Margin, 3Y Avg
- 17.4%
- FCF Margin, Worst Year
- 16.9%
Cash Flow
- Free Cash Flow
- $1.5B
- FCF Yield
- 8.7%
- Owner FCF Yield
- 8.2%
Balance Sheet
- Cash & Equivalents
- $591.9M
Returns & Capital
- Dividends Paid
- $190.3M
- Dividend Yield
- 1.1%
- Dividend Payout, 3Y Avg
- 22.8%
- Share Repurchases
- $487.0M
- Buyback Yield, 3Y Avg
- 4.0%
- SBC, 3Y Avg
- $97.0M
Cash Flow by Year
| Year | Revenue | FCF | Margin |
|---|---|---|---|
| FY2025 | $8.2B | $1.5B | 17.9% |
| FY2024 | $7.7B | $1.3B | 16.9% |
| FY2023 | $7.4B | $1.3B | 17.5% |
| FY2022 | $6.9B | $1.2B | 16.8% |
| FY2021 | $6.8B | $1.4B | 19.9% |
Annual filing data through FY ended December 31, 2025; shares and float as of October 10, 2026. Yields and enterprise value use the calculated market cap above, at its as-of date. Ratios are our calculations from reported figures.
Stronger demand supports expansion as pricing diverges
Healthcare Earnings: Demand Surges, Costs Bite Back